VanEck Associates’s Express Scripts Holding Company ESRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ESRX
ECM
BJL
BSPF
MYAM
AWM
W
ACA
UCFA
SBL
VanEck Associates's ESRX Position: Q4 2018 in Review
VanEck Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 236,937 shares — an estimated $22.5M sold.
VanEck Associates first reported a position in ESRX in Q2 2013 and held it in 18 quarters. The position peaked at $47.8M in Q1 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.
- VanEck Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
- VanEck Associates sold 236,937 Express Scripts Holding Company shares in Q4 2018, an estimated $22.5M.
- VanEck Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 18 quarters.
- VanEck Associates's Express Scripts Holding Company position peaked at $47.8M in Q1 2015.
- 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.
Based on VanEck Associates's 13F filing for Q4 2018, filed 12 Feb 2019.